ArticleBMJ open ophthalmology2019

Patient-reported outcomes in the RELIGHT clinical trial of ranibizumab in diabetic macular oedema.

Usha Chakravarthy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.